Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jaap J M Teunissen
Pitfalls in the Response Evaluation After Peptide Receptor Radionuclide Therapy With [ 177 Lu-Dota 0 ,Tyr 3 ]Octreotate
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Related publications
Peptide Receptor Radionuclide Therapy in Patients With Medullary Thyroid Carcinoma: Predictors and Pitfalls
BMC Cancer
Cancer Research
Oncology
Genetics
Practıcal Aspects of 68Ga-Labelled Dota-Peptides for Peptide-Receptor Radionuclide Therapy
Journal of Engineering Technology and Applied Sciences
Nephrotoxicity After PRRT With 177Lu-Dota-Octreotate
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Predictors of Long-Term Outcome in Patients With Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy With 177Lu-Octreotate
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Peptide Receptor Radionuclide Therapy
Best Practice and Research in Clinical Gastroenterology
Gastroenterology
Peptide Receptor Radionuclide Therapy
[ 177 Lu]-Psma-617 Radionuclide Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer – Author's Reply
The Lancet Oncology
Oncology
New Developments in Peptide Receptor Radionuclide Therapy
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Reply: Peptide Receptor Radionuclide Therapy in the United States
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
